Re-challenging chemotherapy after pembrolizumab in platinum-refractory urothelial carcinoma.

Taizo UchimotoTatsuo FukushimaKazumasa Komura Wataru FukuokayaTakahiro AdachiTakeshi HashimotoAtsuhiko YoshizawaKo NakamuraYusuke YanoKazuki NishimuraKyosuke NishioKeita NakamoriKosuke IwataniShutaro YamamotoFumihiko UrabeKeiichiro Mori Shahrokh F ShariatShunsuke TsudukiKiyoshi TakaharaTeruo InamotoJun MikiTakahiro KimuraYoshio OhnoRyoichi ShirokiShin EgawaHaruhito Azuma

Published in: BJU international (2022)

Re-challenging chemotherapy including platinum agents after PD with pembrolizumab offers clinical benefits in patients with mUC.

Keyphrases

locally advanced
advanced non small cell lung cancer
squamous cell carcinoma
chemotherapy induced
rectal cancer